Trafalgar International (GCAN) Cash & Equivalents (2017 - 2026)
Trafalgar International's Cash & Equivalents was $1,439 in Q1 2026, down 96.9% from $46,213 a year earlier but up 76.6% from the prior quarter.
Trafalgar International (GCAN) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Trafalgar International came in at $815.00, down 98.6% from FY2024.
- Cash & Equivalents has now declined for four consecutive years, with a five-year compound annual growth rate of -62.7% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $57,368 in FY2024 (-65.6%), $166,859 in FY2023 (-38.2%), $270,030 in FY2022 (-28.5%) and $377,520 in FY2021 (+234.2%).
- Quarterly Cash & Equivalents has moved between $815.00 (Q4 2025) and $528,930 (Q2 2021) over five years.
- Compared with a year earlier, Cash & Equivalents has declined for 16 straight quarters, with an average decline of 74.2% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2021 (growth of 234.2%); the worst was Q4 2025 (a decline of 98.6%).
- Per Business Quant data, GCAN's Cash & Equivalents in the three quarters before Q1 2026 was $815.00 (Q4 2025), $21,355 (Q3 2025) and $26,712 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Trafalgar International | 1.51 Mn | 1.51 Mn | - | 1,439.00 |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1,439.00 |
| Dec 31, 2025 | 815.00 |
| Sep 30, 2025 | 21,355.00 |
| Jun 30, 2025 | 26,712.00 |
| Mar 31, 2025 | 46,213.00 |
| Dec 31, 2024 | 57,368.00 |
| Sep 30, 2024 | 62,282.00 |
| Jun 30, 2024 | 80,316.00 |
| Mar 31, 2024 | 129,323.00 |
| Dec 31, 2023 | 166,859.00 |
| Sep 30, 2023 | 199,532.00 |
| Jun 30, 2023 | 240,747.00 |
| Mar 31, 2023 | 251,553.00 |
| Dec 31, 2022 | 270,030.00 |
| Sep 30, 2022 | 289,094.00 |
| Jun 30, 2022 | 311,197.00 |
| Mar 31, 2022 | 367,589.00 |
| Dec 31, 2021 | 377,520.00 |
| Sep 30, 2021 | 456,358.00 |
| Jun 30, 2021 | 528,930.00 |
Trafalgar International Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GCAN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GCAN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GCAN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();